Tag Archive | "sectoral"

Tags: , , , , , , , , , , , , , , ,

Acology Inc – ACOL


Acology, translated from ancient Greek, means “the science of remedies”. Acology, Inc.® markets and sells the TSOS Container™. This container is the first-ever polypropylene air-tight, water-tight, smell-proof delivery and storage container with a built-in grinder. It is manufactured from medical-grade No. 5 polypropylene resin, which is non-porous and non-leaching. These containers are portable and affordable.

These containers give consumers the ability to easily store, carry and grind herbs and herbal remedies, medicines, teas, and other solids or liquids without cross-contamination or leakage.

Products

The Medtainer is versatile in it’s design, being able to traverse numerous consumer needs on the go. Through the product’s ability to embody both air-tite & grinding capabilities, we are able to transcend various markets and expand its everyday uses. Although originally engineered as a solution to break down medication for the needs of Pediatric and Geriatric patients, The Medtainer has now been adopted as an application into markets/industries such as tea, culinary , coffee , pharmaceuticals & veterinary medicine.

The Company intends to develop, market and sell other plastic container products.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , ,

Grizzly Discoveries Inc – GZDIF


Grizzly trades on the TSX Venture Exchange under the symbol GZD, on the OTCQX exchange under the symbol GZDIF, and the Frankfurt Exchange under the symbol G6H, with 48,475,268 common shares issued and outstanding.

Grizzly is an aggressive and diversified Canadian mineral exploration company exploring for: potash in Alberta; world class gold and base metal deposits in British Columbia; and diamonds in Alberta. Grizzly holds, or has an interest in, metallic and industrial mineral permits for potash totaling more than 900,000 acres along the Alberta-Saskatchewan border. Grizzly currently has four precious-base metal properties in British Columbia totaling over 235,000 acres. Grizzly also currently holds more than 600,000 acres in diamond properties, which host diamondiferous kimberlites in the Buffalo Head Hills and Birch Mountains of Alberta.

GRIZZLY DISCOVERIES

• Canadian company focused on precious metals in BC and Potash in Alberta

• Extensive claim holdings in BC and Alberta

• Exploration results returned Gold, Silver, Copper, Platinum, Palladium, Lead, Zinc, Graphite, Potash and Diamonds

• Over 25% owned by Management

• Experienced Management with proven track record of success

• 225,000 acres at Greenwood, BC

• Numerous historic mines in the area

• Over 6 M oz gold produced in area

• Discovered 7 different mineralized areas within Greenwood property

• Ket 28 area diamond drill assays:

- 2.77 g/t Au over 11.0 m

- 11.9 g/t Au over 2.0 m

• Ket 28 area 7 km north of Kinross Buckhorn mine and mill

• Near surface high grade gold open pit potential

• Gold, Silver, Copper, Platinum, Palladium, Lead, Zinc, Graphite

• GZD has spent >$6 M to date

• French and Peak claims in northern BC contain Gold, Silver, Copper, Zinc

• Three diamondiferous kimberlites and four others discovered on Alberta diamond properties

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

PuraMedBioScience™


Mission

PuraMed BioScience®, Inc., is a pharmaceutical company specializing in the research, development, and marketing of safe, highly effective, non-prescription medicinal and healthcare products with the purpose of reaching and improving the quality of life for underserved populations in the OTC marketplace.

By applying hard science to natural products, PuraMed BioScience is committed to the establishment of a leadership position in the OTC natural and alternative health remedy market by introducing a safe and effective product line” that delivers better performance with fewer side effects than its chemical counterparts.

PuraMed BioScience recently formed a new division within the company to research, develop, and distribute a line of products incorporating hemp-derived cannabinoids as key components. The company plans to launch additional cannabinoid-enhanced, anti-inflammatory and anxiolytic products as it moves forward in the development of its CBD product line.

PuraMed BioScience, Inc., employs the use of double-blind placebo controlled testing to establish efficacy and safety benchmarks for products made with natural ingredients. Using this information, PuraMed BioScience directs marketing efforts directly to the consumer, retail, and product-related patient populations.

LipiGesic M, PuraMed’s flagship formulation, is a homeopathic medication using feverfew and ginger delivered sublingually (under the tongue) for the relief of migraine pain and associated symptoms. This initial product from the company has been clinically tested and featured in three (3) top-tier medical journals with articles authored by America’s leading migraine headache experts.

Based on the results of the clinical trials, LipiGesic M has an efficacy that is comparable to the top-selling triptan medication. However, LipiGesic M has an excellent safety profile, is non-drowsy and has no reported interactions with other medications. With this initial product, PuraMed BioScience has met the criteria the company set to create a superior natural product that works better than its chemical counterpart in the resolution of migraine pain and associated symptoms.

About the Company

PuraMed BioScience was established to capture two unique opportunities. The first is to build a substantial and profitable business with the distribution of LipiGesic® M a formulation created for the acute relief of migraine headaches. PuraMed BioScience is also reviewing several third-party health and wellness products that can be incorporated into the company’s product offering. Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class.

The second, longer-term, opportunity is to establish a leadership position in the highly fragmented OTC natural and alternative-health remedy market by introducing a “new kind of product line.” The PuraMed BioScience product line will consist of ‘alternative’ remedies for common ailments. With effective messaging campaigns, these products have the potential to be adopted by the majority, many of whom prefer ‘natural’ alternatives, provided there is no need to sacrifice performance or convenience.

Company Management

Each member of the PuraMed BioScience management team brings decades of experience needed to compete in the over-the-counter and alternative health industry. This experience includes product development, drug formulation, direct marketing, sales, regulatory compliance and approval, and senior management of both public and private companies.

Business Strategy

PuraMed BioScience® Inc., intends to execute according to the following seven-step strategy.

1. Identify effective products with large market opportunities.

2. Employ a unique and effective delivery system.

3. Perform clinical trials and obtain clinical results to overcome consumer skepticism.

4. Employ a direct-response sales campaign to refine the consumer message and generate initial revenue.

5. Achieve broad, retail distribution to provide easy and widespread consumer access.

6. Apply effective marketing to drive consumer awareness and the buying impulse.

7. Capture “first-mover” advantage.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

DC Brands International Inc – HRDN


Company History

  • Started in 2004 as an Energy Drink Company
  • Dickens Energy Cider
  • Turn Left Energy Drink
  • In 2007 entered the Nutritional Beverage Space – Hard Nutrition
  • Functional Water System: Nine Functions
  • Weight Loss
  • 5 Hours Mental Acuity
  • Full Body Cleanse
  • Hangover Relief
  • Pre & Post Workout
  • 10 Hours All Natural Energy
  • Daily Vitamins
  • In 88 King Sooper’s (Kroger Brand) Grocery Stores along Front Range of Colorado
  • Lost Funding Jan 2013 began restructuring
  • Purchased 15% of Village Tea Company – New York Based Premium loose leaf tea.
  • April 2014 – Announced entry into Colorado Marijuana Industry
  • June 2014 – Signed contract with 1st Client

Colorado Marijuana Industry

  • 2000 Medical Marijuana approved
  • JAN 2014 Recreational Marijuana Sales Began
  • Approximately 500 licenses issued originally
  • In 2014 approximately 225 licenses canceled due to regulatory issues
  • Company’s opinion is regulators are trying to move out the small operators/stoners and get the larger operators/business people involved

Dc Brands Green Investments, Llc Value Proposition

  • Green will offer a bundle of services to Colorado Marijuana Growers and Sellers
  • Accounting
  • Payroll
  • Cash Flow Management
  • Tax Payments
  • Security
  • Laboratory Testing
  • AND Capital for Expansion or Acquisitions
  • In Exchange GREEN will receive a variable rate contract loosely based upon an agreed upon % of sales
  • $1 million invested properly should return approx. $500k in yr 1; $1 million yr 2, $2 million yr 3

Dc Capital Structure

  • 3.8 Billion Shares currently outstanding
  • 5 Billion Common shares authorized
  • 14-C Definitive filed June 6, 2014 increasing authorized to 30 Billion effective June 29, 2014
  • Series A Preferred Stock provides 51.25% voting control – owned by Bob Armstrong CEO
  • Series B –G Preferred Stock convertible into approx. 30% of the company
  • $1 million Senior Secured Debt secured by all assets of DC held by Richard Pearce – former CEO
  • $5 million of unsecured debt (approx.) held by 40 lenders

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , ,

EXEO Entertainment Inc – EXEO


Headquartered in Las Vegas, Nevada Exeo Entertainment, Inc. is public company listed on the OTCBB and traded under the symbol “EXEO.” They develop, acquire, manufacture, license and distribute unique products in the video gaming, music, and smart TV sectors.

Exeo markets its products under the following brands: Psyko™ Audio, Krankz™ Audio, Zaaz™ keyboards, and the Extreme Gamer®. They seek to develop, license, and distribute products within the interactive entertainment sector that fill a clearly defined need and provide above average shareholder returns.

They began operations in May 2011 when they executed a license agreement with Digital Extreme Technologies, Inc. to complete product development and commercialization on the Extreme Gamer®, the Zaaz™ keyboard, and the portable gaming system. In 2013 they executed a license agreement with Psyko Audio Labs Canada to market the patented Psyko Krypton & Carbon 5.1 gaming headphones.

They are currently working on securing distribution and making the products available to consumers through big box retailers.

Highlights

  • EXEO is rated a strong long-term buy based on the quality of its product offerings in three distinct sectors: video gaming, audio, and Smart TVs.
  • EXEO’s current products include: Psyko 5.1 Gaming Headphones, Krankz Wireless Bluetooth On-Ear Headphones, and Zaaz Smart TV Keyboards.
  • EXEO needs to effectively communicate its story to consumers and implement a solid marketing campaign to pull sales through established retail channels.
  • If EXEO can execute its plan, there is the potential for $100 million in sales.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , ,

China opens monopoly probe into Qualcomm


Qualcomm Inc. said a Chinese government agency is investigating the chip maker under the country’s antimonopoly law, a probe that comes amid rising tensions affecting U.S. companies in the fast-growing market for high-tech products.

Qualcomm’s chief executive recently acknowledged that U.S. restrictions on Chinese companies and revelations about surveillance by the National Security Agency are affecting its business in China.

But close scrutiny of Qualcomm’s business practices in Asia began long before recent NSA revelations. The company is the largest maker of processors and communications chips for mobile phones, serving customers that include Apple Inc. and Samsung Electronics Co. It has a particularly dominant position in the high-speed technology called LTE that Chinese carriers are moving to adopt.

Qualcomm charges patent royalties to handset makers that use its chips, and dealings associated with that business have triggered antitrust cases in South Korea and Japan. The company is appealing adverse rulings in both countries.

The company said Monday it isn’t aware of any activity that violates the antimonopoly law and will continue to cooperate with the National Development and Reform Commission, which partly oversees antitrust issues and commenced the investigation.

China has been using its five-year-old antimonopoly law to push down prices in a variety of industries ranging from cars to baby formula. Experts say the efforts are part of a move to keep a lid on inflation, even as the new law helps give Beijing a greater say in the global marketplace.

Chinese firms have invested heavily in technology, helping to build industry giants like Huawei Technologies Co. and ZTE Corp. Much of the investment has come amid prodding by Beijing, which wants to shift away from China’s traditional dependence on cheap manufacturing to sell innovative products that can compete globally.

Qualcomm maintained a 53% share of the global market for smartphone processors in the second quarter of 2013, according to Strategy Analytics. It beat most rivals to market with chips that can use LTE networks, and is particularly strong in chips that can also communicate using older cellular technologies.

The company’s share of such LTE chips stood at greater than 98% in 2012, estimates Will Strauss, an analyst with Forward Concepts.

Meanwhile, smartphone makers that want to combine LTE with older technologies face the prospect of paying Qualcomm a patent royalty. “A lot of people dislike that,” Mr. Strauss said.

In semiconductors, China lags well behind foreign competitors, in some cases using acquisitions to try to catch up.

In July Tsinghua Unigroup Ltd., a state-run company, agreed to acquire Spreadtrum Communications Inc., and earlier this month it struck a deal to acquire RDA Microelectronics Inc., a wireless chipset maker.

Qualcomm recorded about $12.3 billion in revenue from China in the fiscal year ended in September, or about half of the company’s total revenue.

At an analyst meeting in New York last week, Chief Executive Paul Jacobs discussed the prospects of even larger sales in China as LTE networks begin launching in 2014.

Separately, in an interview with The Wall Street Journal, Mr. Jacobs said the de facto U.S. ban on telecom gear maker Huawei and revelations about NSA spying are affecting its business in the country. Recently, Cisco Systems Inc. executives suggested Chinese customers, particularly those with government ties, may be cutting purchases of U.S. tech gear in response to fallout from such issues.

“We are definitely seeing increased pressure,” Mr. Jacobs said. “All U.S. tech companies are seeing pressure.”

Mr. Jacobs stopped short of saying the pressure hurt Qualcomm’s sales, but he did say it affected the way the company operated in China.

“[You] have to be very cautious,” he said. “We are always very careful with whatever steps we take. How we sell. How we interact.”

Qualcomm works with some local Chinese manufacturers and builds some of its computer chipsets in mainland China, Mr. Jacobs said. The company doesn’t build cutting-edge technology there, however.

A U.S. congressional investigation last year concluded that Huawei and ZTE pose security risks to the U.S. because their telecom equipment could be used for spying on Americans. Huawei and ZTE have repeatedly denied the allegations.

In many countries, Mr. Jacobs said, local companies “can complain and get government support” that could lead to an investigation of a foreign company. “That stuff happens,” he said. “I think Huawei looks at it.”

Since 2009, when China used the new antimonopoly law to break apart Coca-Cola Co.’s $2.4 billion effort to acquire a Chinese juice maker, Beijing has shown its willingness to use the law against foreign companies.

Still, domestic companies haven’t been immune. Two years ago, the NDRC said it was looking into state-run telecom giants China Unicom (HK) Ltd. and China Telecom Corp. for potential anti-monopolistic practices.

The two later said they would increase broadband speeds and lower prices.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

SOURCE: http://www.marketwatch.com/story/china-opens-monopoly-probe-into-qualcomm-2013-11-25

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , ,

Puget Technologies Inc – PUGE


Puget Technologies is growing fast and working hard to ensure maximum returns for its shareholders. The board of directors and management of Puget Technology are committed to establishing and encouraging a conscientious business environment and always operating in a responsible and ethical manner. Puget only works with top-rated, reputable companies. Puget Technologies firmly believes this commitment, along with sound management practices, is the cornerstone to maintaining the trust of its investors, employees and consumers. Puget’s business practices are reflective of the requirements of applicable securities laws and stock exchange requirements.
Puget Technologies mission is to develop the company’s presence throughout the United States by:
  • Partnering with companies which offer leading edge consumer oriented products and technologies, and taking them to the next level.
  • Conducting product research and development that will result in the commercialization of well-manufactured, forward-looking products.
  • Offering consumers improved and/or more versatile options over existing products.
  • Offering our products to consumers in a responsible manner.
  • Maintaining the highest ethical standards in all business endeavors.
Puget Technologies vision is to become a leader in each of the industries in which it is involved by responsibly delivering quality, innovative products to consumers.

Cannabis Biotech, a wholly owned subsidiary of Puget Technologies ( OTC: PUGE ), is a forward thinking publicly held company dedicated to the development of patented and proprietary health, wellness and medical grade cannabinoid products.

http://www.cannabisbiotech.com/wp-content/uploads/2013/10/about1.jpg

Cannabis Biotech conducts cutting edge research to develop innovative cannabinoid products and therapies for the treatment of diseases and their symptoms including HIV, cancer, glaucoma and neurological disorders.

An increasing number of states in the U.S. and numerous countries have legalized or recognized the use of cannabinoid products and treatments, changing public attitudes as science demonstrates the benefits for the products in the management of certain diseases and conditions.

Headquartered in Ft. Lauderdale, Florida, Cannabis Biotech is led by Ron Leyland, who has demonstrated ability to identify trends, generate new products, produce and develop branding for individual products and product lines, create innovative sales and distribution strategies domestically and internationally, while maintaining the highest standards.

Visit their website : http://www.cannabisbiotech.com/

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , ,

Cablevision swings to third-quarter profit


Cablevision Systems Corp. CVC -2.11% swung to a third-quarter profit as the cable operator reported higher revenue, though customer rolls shrank.

While Cablevision maintains a high penetration of video, broadband and voice services in its main coverage area around New York City, it has faced increased competition in its own backyard from telecommunications peers, such as Verizon Communications Inc.’s (VZ) fiber-optics services, as well as streaming-video services like Netflix Inc. (NFLX).

Cablevision this year sought to sharpen its focus on its core market, agreeing to sell the western cable system it bought just a few years ago to Charter Communications Inc. (CHTR) for $1.6 billion. The move helped Cablevision to maintain one of its strengths of being regionally clustered, which has allowed it to be efficient in marketing and in deploying services like digital cable and cloud-based digital video recording faster than other cable operators.

Also, in April Bow Tie Cinemas agreed to buy all of the Clearview Cinemas theaters from Cablevision.

The Long Island-based company reported it lost 37,000 video customers, 18,000 voice subscribers and 13,000 high-speed data customers since the second quarter.

Total customers reached 3.2 million, down 29,000 from the second quarter.

Overall, Cablevision reported a profit of $294.6 million, or $1.10 a share, compared with a year-earlier loss of $3.8 million, or a penny a share. The year-ago period included losses on extinguishment of debt and certain write-offs of $61.1 million, compared with similar losses of $16.5 million in the latest period. Per-share earnings from continuing operations, which exclude its western cable system and Clearview, rose to 22 cents from a penny.

Revenue grew 1.8% to $1.57 billion.

Analysts polled by Thomson Reuters were looking for a per-share profit from continuing operations of 11 cents on $1.57 billion in revenue.

Shares closed Thursday at $15.63 and were inactive premarket. The stock has risen 4.6% so far this year.

Write to Ben Fox Rubin at ben.rubin@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

SOURCE: http://www.marketwatch.com/story/cablevision-swings-to-third-quarter-profit-2013-11-08-104851148

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Readen Holding Corp – RHCO


Readen Holding Corp, a Venture Capital organisation,investor and shareholder of companies operating in hree separate industries. Readen Holding Corp. has access to an extensive, influential and loyal network of business relations and investors.

Readen Group’s mission statement is to be a valuable partner for customers in terms of technical flexibility, quality and competitive pricing through the complete value chain (SIM cards, mobile phones and applications).

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , ,

E-Waste Systems, Inc – EWSI


E-Waste Systems, Inc. (OTCQB:EWSI), through its subsidiaries and affiliates, offers customized end-to-end solutions in IT Asset Recovery, E-Waste Management, and Electronics Reverse Logistics.

Leveraging its affiliates’ complementary geographies, technical capabilities, and strong supplier relationships, EWSI expands the services offered to customers, cross-fertilizes best management practices, streamlines logistics, aggregates volumes, and invests in cutting-edge recycling technologies.

Their Focus:

  • Leadership in safe, compliant, and ethical e-waste disposal
  • Global delivery of services
  • Application of state-of-the-art technology and engineering
  • Posted in Featured, Stock NewsComments Off

    Advertise Here